Factors associated with normal or abnormal Papanicolaou smear among HIV-infected women at a national hospital in Lima, Peru, 2012-2015.
Omayra Jannet Chincha LinoNathaly Olga Chinchihualpa ParedesFrine Samalvides CubaPublished in: AIDS care (2021)
HIV-infected women are at a risk of developing abnormal lesions of the uterine cervix. The objective of this study was to determine factors associated with normal or abnormal Papanicolaou (Pap) smear among HIV-infected women. A case-control study was conducted; case and control were defined as HIV-infected women ≥18 years with an abnormal and normal Pap smear, respectively. A logistic regression analysis was performed, and the Odds Ratio (OR) was calculated with its 95% Confidence Interval (CI). We included 368 patients, and the mean age was 36.83 years (SD ± 9.81), similar between cases and controls. Regarding cases, 30.50% (n = 43) had an alcohol consumption (AC), 75.18% (n = 106) were on antiretroviral therapy (ART) and 37.74% (n = 40) were in virologic failure (VF). About controls, 18.02% (n = 41) had AC, 85.02% (n = 193) were on ART, and 23.12% (n = 40) were in VF. In multivariate analysis, AC [OR: 1.77 (1.06-2.95)], VF [OR: 2.41 (1.55-3.74)], and ART [OR: 0.07 (0.02-0.23)] were significant factors. The risk factors associated with an abnormal Pap smear were AC and VF. ART was a protective factor. Therefore, besides scheduled Pap smear, human papillomavirus screening/immunization, VF, and ART should be strictly reinforced, and AC should be mitigated.
Keyphrases
- hiv infected
- antiretroviral therapy
- pulmonary tuberculosis
- human immunodeficiency virus
- polycystic ovary syndrome
- hiv positive
- hiv infected patients
- hiv aids
- pregnancy outcomes
- alcohol consumption
- cervical cancer screening
- mycobacterium tuberculosis
- healthcare
- ejection fraction
- breast cancer risk
- end stage renal disease
- pregnant women
- newly diagnosed
- insulin resistance
- type diabetes
- skeletal muscle
- metabolic syndrome
- prognostic factors
- men who have sex with men
- hepatitis c virus
- tissue engineering